SCA
STJ

SAC Capital Advisors’s St Jude Medical STJ Stock Holding History

SAC Capital Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-369,148
Closed -$24.1M – 1432
2014
Q1 		$24.1M Buy
369,148
+349,196
+1,750% +$22.7M 0.13% 227
2013
Q4 		$1.24M Sell
19,952
-253,792
-93% -$14.7M 0.01% 850
2013
Q3 		$14.7M Buy
273,744
+254,006
+1,287% +$13.1M 0.08% 293
2013
Q2 		$901K Buy
+19,738
New +$855K 0.01% 949

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's STJ Position: Q2 2014 in Review

SAC Capital Advisors sold out of St Jude Medical (STJ) in Q2 2014, closing a stake of 369,148 shares — an estimated $24.1M sold.

SAC Capital Advisors first reported a position in STJ in Q2 2013 and held it in 4 quarters. The position peaked at $24.1M in Q1 2014. 555 funds tracked by Wall St. Rank hold STJ as of Q2 2014.

  • SAC Capital Advisors reported no remaining St Jude Medical position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 369,148 St Jude Medical shares in Q2 2014, an estimated $24.1M.
  • SAC Capital Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's St Jude Medical position peaked at $24.1M in Q1 2014.
  • 555 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.